reports
Moody's Ratings affirms Amgen's Baa1 ratings; revises outlook to stabl...
Moody's Ratings (Moody's) affirmed the ratings of Amgen Inc. (Amgen) including the Baa1 senior unsecured notes rating, (P)Baa1 senior unsecured shelf rating, (P)Baa1 senior unsecured medium term note program rating, and Prime-2 commercial paper rating. At the same time, we revised Amgen's outlook to...
Moody's announces completion of a periodic review of ratings of Amgen ...
Moody's Ratings has completed a periodic review of the ratings of Amgen Inc. and other ratings that are associated with this issuer. The review was conducted through a rating committee held on 7 March 2024 in which Moody's reassessed the appropriateness of the ratings in the context of the relevant...
- Dave Nicoski
- Ross LaDuke
Vital Signs: Actionable charts
In this product we rank the most positive and negative domestic stocks, filter the symbols by market-cap and trading volume, and then divide the companies into sectors and groups. We then manually look through charts leadership/changes, bottoms-up/top-down ideas, short-term patterns that may have long-term significance, etc. We believe you will find this product valuable as significant price and relative moves begin in the daily charts.
WLDN WILLDAN GROUP
TDS TELEPHONE AND DATA SYSTEMS INC.
OSUR ORASURE TECHNOLOGIES INC.
ICFI ICF INTERNATIONAL INC.
BGS B&G FOODS INC.
BCRX BIOCRYST PHARMACEUTICALS INC.
QUAD QUAD/GRAPHICS INC. CLASS A
GTN GRAY TELEVISION INC.
USM UNITED STATES CELLULAR CORP
INFU INFUSYSTEMS HOLDINGS INC.
IRTC IRHYTHM TECHNOLOGIES INC.
URGN UROGEN PHARMA
DESP DESPEGAR.COM CORP.
BKNG BOOKING HOLDINGS INC.
ALEC ALECTOR
PGNY PROGYNY
ACEL ACCEL ENTERTAINMENT (A)
PRDO PERDOCEO EDUCATION CORP
LSEA LANDSEA HOMES CORP (A)
DFH DREAM FINDERS HOMES
PHVS PHARVARIS NV
DKNG AMGEN INC
GLSI DRAFTKINGS INC.
GREENWICH LIFESCIENCES INC
- Dave Nicoski
- Ross LaDuke
Vermilion Short Shots: Technically Vulnerable Stocks
n this product we rank the most positive and negative domestic stocks, filter the symbols by market-cap and trading volume, and then divide the companies into sectors and groups. We then manually look through charts leadership/changes, bottoms-up/top-down ideas, short-tShort Shots is a collection of technically vulnerable charts culled from the Negative Inflecting and Toppy columns within our Weekly Compass report or from various technical screening processes. The charts contained in this report...
IEX IDEX CORPORATION
AMGN AMGEN INC.
DHR DANAHER CORPORATION
MMM 3M COMPANY
CMI CUMMINS INC.
STLD STEEL DYNAMICS INC.
SEE SEALED AIR CORPORATION
QCOM QUALCOMM INC
NWL NEWELL BRANDS INC
MOS MOSAIC COMPANY
LEA LEAR CORPORATION
J7Z JAZZ PHARMACEUTICALS PUBLIC LIMITED COMPANY
IP INTERNATIONAL PAPER COMPANY
HAIN HAIN CELESTIAL GROUP INC.
ERICn TELEFONAKTIEBOLAGET LM ERICSSON
DE DEERE & COMPANY
DCO DUCOMMUN INC.
CPRX CATALYST PHARMACEUTICALS
BMY BRISTOL-MYERS SQUIBB COMPANY
APOG APOGEE ENTERPRISES INC.
AWI ARMSTRONG WORLD INDUSTRIES INC.
ENB. ENBRIDGE INC.
MLHR HERMAN MILLER INC.
VFC V.F. CORPORATION
UTHR UNITED THERAPEUTICS CORPORATION
PFE PFIZER INC.
WRK WESTROCK COMPANY
NTR NUTRIEN LTD.
ABBV ABBVIE INC.
KDP KEURIG DR PEPPER INC.
LEVI LEVI STRAUSS & CO. CLASS A
SILK SILK ROAD MEDICAL
CTVA CORTEVA INC
LHX L3HARRIS TECHNOLOGIES INC
WAT LYXOR ETF WORLD WATER/FRANCE
SIMO PAPER MIDDLE EAST(SIMO)
SBSW SIBANYE-STILLWATER LTD
NSPI NATIONAL SPINNING & WEAVING CO.
Moody's: Amgen's and Horizon Therapeutics' ratings unaffected by FTC r...
Moody's Investors Service (Moody's) commented that the ratings and outlooks of Amgen Inc. ("Amgen") and Horizon Therapeutics USA Ltd, a subsidiary of Horizon Therapeutics plc (collectively "Horizon") are unaffected by the announcement that the US Federal Trade Commission is seeking to block Amgen's ...
- Brian Moretta
- Mark Thomas
- Martin Hall
- Riccardo Bindi
Hardman & Co Monthly: April 2023
Feature article: 2022 Pharma Statistics - 8.7% growth – but worrying signs An efficient reporting system has seen all the listed multinational pharmaceutical companies announcing results for 2022, which has given us the opportunity to update our industry statistics and drug database. This report provides the first snapshot of the global and US rankings of the top 20 drug companies for 2022. 2022 was characterised by 8.7% underlying growth, offset by a large forex impact (-12%), due to USD stren...
INCY INCYTE CORP
IPN IPSEN SA
NOVN NOVARTIS AG
VRTX VERTEX PHARMACEUTICALS INCORPORATED
TEVA.N TEVA PHARMACEUTICAL INDUSTRIES LIMITED SPONSORED ADR
REGN REGENERON PHARMACEUTICALS INC.
LLY MERCK & CO. INC.
JNJ ELI LILLY AND COMPANY
J7Z JOHNSON & JOHNSON
HZNP JAZZ PHARMACEUTICALS PUBLIC LIMITED COMPANY
GILD HORIZON THERAPEUTICS PUBLIC LIMITED COMPANY
BMY GILEAD SCIENCES INC.
BIIB BRISTOL-MYERS SQUIBB COMPANY
FEV BIOGEN INC.
IBT FIDELITY EUROPEAN VALUES PLC
FCSS INTERNATIONAL BIOTECHNOLOGY TRUST PLC
FSV FIDELITY CHINA SPECIAL SITUATIONS PLC
FJV FIDELITY SPECIAL VALUES PLC
FAS FIDELITY JAPAN TRUST
AVO FIDELITY ASIAN VALUES PLC
CLIG ADVANCED ONCOTHERAPY
MRK CITY OF LONDON INVESTMENT GROUP
NOVO B MERCK KGAA
novob NOVO NORDISK A/S CLASS B
RECI NOVO NORDISK
SAN REAL ESTATE CREDIT INVESTMENTS
UCB SANOFI
HIK UCB S.A.
PIN HIKMA PHARMACEUTICALS PLC
PFIZER PANTHEON INTERNATIONAL
4506 PFIZER
4523 SUMITOMO DAINIPPON PHARMA CO. LTD.
4507 EISAI CO. LTD.
4568 SHIONOGI & CO. LTD.
VTAS DAIICHI SANKYO COMPANY LIMITED
STX VOLTA FINANCE (GBP)
4502 SHIELD THERAPEUTICS
HAT TAKEDA PHARMACEUTICAL CO. LTD.
OCI H&T GROUP
4578 OAKLEY CAPITAL INVESTMENTS
APAX OTSUKA HOLDINGS CO. LTD.
4503 APAX GLOBAL ALPHA
ICGT ASTELLAS PHARMA INC.
UTHR ICG ENTERPRISE TRUST
PFE UNITED THERAPEUTICS CORPORATION
AZN PFIZER INC.
GLAXO ASTRAZENECA PLC
ABBV GLAXOSMITHKLINE PHARMACEUTICALS
VRX CN ASTELLAS PHARMA INC
MRNA ABBVIE INC.
TXG BAUSCH HEALTH COMPANIES INC.
NOVO MODERNA INC.
VTRS 10X GENOMICS INC CLASS A
4568.T NOVO NORDISK A/S-B
ME VIATRIS INC.
OCL DAIICHI SANKYO COMPANY
LUND A LIMITED
23ANDME HLDG CO
OAKLEY CAPITAL
H. LUNDBECK A/S
Moody's assigns Baa1 rating to Amgen's new sr. notes; negative outlook
Moody's Investors Service ("Moody's") assigned a Baa1 rating to the new senior unsecured notes offering of Amgen Inc. ("Amgen"). There are no changes to Amgen's existing ratings including the Baa1 senior unsecured rating or the P-2 commercial paper rating, and the outlook is unchanged at negative. ...
Unfortunately, this report is not available for the investor type or country you selected.
Report is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.